Equine

Equest Pramox now licensed for use in pregnant and lactating mares

vetreportJanuary 31, 2014

London, UK 31 January 2014 – Equest Pramox oral gel, produced by Zoetis has been licensed for use in breeding, pregnant and lactating mares and has been shown not to adversely affect the fertility of mares.

Equest Pramox is an oral gel containing moxidectin and praziquantel for single dose control of all three species of tapeworm, roundworms – including encysted larval stages of small redworms, and bots.

Equest Pramox and Equest are the only equine wormers to contain moxidectin, providing comprehensive worm control and the longest recommended dosing interval of any equine wormer currently available.

Moxidectin is a second generation macrocyclic lactone (ML). It has a different chemical structure to the other MLs such as ivermectin, giving it unique properties which include a persistent effect in preventing infection by small strongyles for two weeks after dosing, the treatment of encysted small redworm with a single dose and a 13 week recommended dosing interval.